A phase I trial of vaccination with lethally irradiated lymphoma cells admixed with granulocyte-macrophage colony-stimulating factor secreting K562 cells for the treatment of follicular lymphoma.

Saved in:
Bibliographic Details
Title: A phase I trial of vaccination with lethally irradiated lymphoma cells admixed with granulocyte-macrophage colony-stimulating factor secreting K562 cells for the treatment of follicular lymphoma.
Authors: Jacobsen, Eric1 (AUTHOR) edjacobsen@partners.org, Plant, Ashley2,3 (AUTHOR), Redd, Robert4 (AUTHOR), Armand, Philippe1 (AUTHOR), McDonough, Mikaela1 (AUTHOR), Ihuoma, Udochukwu1 (AUTHOR), Fisher, David C.1 (AUTHOR), LaCasce, Ann1 (AUTHOR), Ritz, Jerome1 (AUTHOR), Dranoff, Glenn5 (AUTHOR), Freedman, Arnold1 (AUTHOR)
Source: Leukemia & Lymphoma. Dec2024, Vol. 65 Issue 12, p1864-1874. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10428194
DOI:10.1080/10428194.2024.2381651